Northrop's EW Suite Achieves New Milestone: Time to Buy the Stock?

In This Article:

Northrop Grumman Corporation NOC recently achieved a major milestone with the successful operational assessment flight testing of its Integrated Viper Electronic Warfare Suite (“IVEWS”) on U.S. Air Force F-16 jets. The system proved its effectiveness against advanced radar-guided threats in complex, real-world scenarios, strengthening its potential for full-scale production and deployment.

The testing also demonstrated IVEWS’ seamless digital interoperability with Northrop’s SABR radar, enabling simultaneous electronic warfare and targeting. This achievement highlights Northrop’s leadership in next-gen defense technology and reinforces its growth prospects in the defense electronics segment. 
With rapidly rising demand for advanced military systems worldwide, this development might encourage investors to add NOC stocks to their portfolios.

However, before making any hasty decision, let’s delve into the company’s year-to-date performance, growth prospects and risks (if any) to investing in the same.

NOC Stock Outperforms S&P 500, Lags Industry & Sector

Shares of Northrop have rallied 4% in the year-to-date period, underperforming the Zacks aerospace-defense industry’s growth of 8.3% as well as the broader Zacks Aerospace sector’s growth of 9.2%. NOC, however, surpassed the S&P 500’s fall of 4.3% in the past year.

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

A similar upward trend can be witnessed in the share price return of other industry players like Embraer ERJ and The Boeing Company BA, which have seen an increase of 26.7% and 5.1%, respectively, in the year-to-date period.

What is Driving NOC Stock Up?

Northrop’s strong presence in Air Force, Space & Cyber Security programs, with its product line being well-positioned in high-priority categories, such as defense electronics, unmanned aircraft and missile defense, has always played the role of a key catalyst in the company’s growth story. Such order flows culminate in a strong backlog count for the company, bolstering its revenue prospects. This might have been reflected in NOC's year-to-date share price hike.

Northrop’s backlog as of March 31, 2025, totaled a solid $92.80 billion. The company expects to recognize approximately 40% and 65% as revenues over the next 12 months and 24 months, respectively, with the remainder to be recognized thereafter.

Northrop’s stable financial position must have also been attracting investors. Its cash and cash equivalents totaled $1.69 billion. Its long-term debt was $14.17 billion as of March 31, 2025, while its current debt was nil. Hence, it would be safe to conclude that the stock holds a strong solvency position, at least in the near term.